---
layout: post
title: "Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2024"
date: 2026-02-05 18:57:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-23374
original_published: 2023-10-23 00:00:00 +0000
significance: 8.00
---

# Animal Generic Drug User Fee Program Rates and Payment Procedures for Fiscal Year 2024

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** October 23, 2023 00:00 UTC
**Document Number:** 2023-23374

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the fee rates and payment procedures for fiscal year (FY) 2024 generic new animal drug program user fees. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Animal Generic Drug User Fee Amendments of 2023 (AGDUFA IV), authorizes FDA to collect user fees for certain abbreviated applications for generic new animal drugs, for certain generic new animal drug products, for certain sponsors of such abbreviated applications for generic new animal drugs and/or investigational submissions for generic new animal drugs, and for certain submissions related to generic investigational new animal drug (JINAD) files. This notice establishes the fee rates for FY 2024.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/10/23/2023-23374/animal-generic-drug-user-fee-program-rates-and-payment-procedures-for-fiscal-year-2024)
- API: https://www.federalregister.gov/api/v1/documents/2023-23374

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
